Lv5
1490 积分 2022-07-05 加入
Mapping systemic lupus erythematosus heterogeneity at the single-cell level
5个月前
已完结
Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
5个月前
已完结
Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system autoimmunity
6个月前
已完结
Chimeric antigen receptor T cell therapy for autoimmune diseases
7个月前
已完结
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
9个月前
已完结
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study
9个月前
已完结
Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells
9个月前
已完结
Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results
9个月前
已完结
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
10个月前
已完结
皖公网安备34019202002308
